In:
Cancer, Wiley, Vol. 120, No. 22 ( 2014-11-15), p. 3562-3568
Abstract:
The current Surveillance, Epidemiology, and End Results analysis demonstrated a significant survival benefit for adjuvant radiotherapy among patients with diffuse‐type gastric cancer. The standard treatment will likely remain controversial until evidence becomes available from phase 3 randomized trials exclusively for diffuse‐type gastric cancer.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v120.22
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1